Here are the top stories covered by DocWire News this week in the Hematology & Oncology section. This week, various research on exercise and cancer links was reported, a study found colorectal and pancreatic cancer rates have increased, and more.
A large study spanning 195 countries found that colorectal and pancreatic cancer rates have increased by 10% between 1990 and 2017, according to a study published in The Lancet Gastroenterology & Hepatology.
A study published in Blood Advances observed significant differences in the use of novel therapy and autologous hematopoietic cell transplantation among various racial/ethnic groups with multiple myeloma.
Exercise intolerance may be related to neurocognitive deficits in acute lymphocytic leukemia survivors, according to research published in Cancer.
Men who are current or former smokers who have higher cardiorespiratory fitness may be less likely to develop lung cancer and have a reduced risk of mortality, according to research published in the American Journal of Preventive Medicine.
Researchers have outlined new exercise recommendations for cancer patients. The paper was published in A Cancer Journal for Clinicians.
In case you missed it, more hem/onc headlines are featured below:
- FDA Expands Approval of Zejula® (niraparib) for Late-Stage Ovarian, Gynecologic Cancers
- Aspirin Reduces Death Risk in Rare Cancer
- Nivolumab Monotherapy or With Ipilimumab Effective for Melanoma Patients
- Researchers Identify New Approach to Administering Cancer Radiation
- Adjuvant Trastuzumab in HR+ and HR− HER2+ Breast Cancer